People
Recipharm has announced that its 2018 International Environmental Award will be presented to Dr. Bryan Brooks, Distinguished Professor in Environmental Science and Biomedical Studies at Baylor University in Waco, Texas.
Privately-held Swedish pharmaceutical company Lobsor Pharmaceuticals AB is eying the U.S. market for a potential treatment for neurodegenerative diseases such as Parkinson’s disease.
Arizona is not exactly the first place one thinks of when it comes to the life sciences. But, like many states and municipalities, Arizona and Phoenix, Arizona, are working hard to grow the life science industry. According to AZBio, bioscience companies in Arizona employed 25,686 people in 2016 in 1,310 individual businesses.
Biotech and pharma companies from across Europe and Asia provide updates on pipeline and business activities.
One year after spinning out from AstraZeneca’s MedImmune, Viela Bio is already anticipating filing a Biologics License Application with the U.S. Food and Drug Administration for its lead asset, inebilizumab.
For years, the biggest employers of science and engineering PhDs has been academic institutions. For example, according to the U.S. National Science Foundation (NSF)’s biennial Survey of Doctoral Recipients, academia employed 11 percent more PhDs than the private sector in 1997.
In the cannabis sector of drug development, there is a movement happening. And Rob Davidson, chief executive officer of CURE Pharmaceuticals is making sure his company is ready for the next steps.
This morning Starboard Value LP issued an investor presentation opposing the proposed deal. The group will share the materials with other shareholders in hopes to sway support for its opposition.
The French company has an age limit for its top official and the company is working on a succession plan in anticipation of that change.
The Nomination Committee has consisted of Axel Calissendorff, Chairman of the nomination committee, Lars Backsell, Johan Lannebo and Ossian Ekdahl.
PRESS RELEASES